Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -14.20%139M | -2,123.08%-289M | -22.49%162M | 67.50%-13M | 23.67%209M | -115.81%-40M | -27.78%169M | -6.30%253M | 141.24%234M | 5.47%270M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 0.00%-25M | ---- | 7.41%-25M | ---- | -8.00%-27M | ---- | 16.67%-25M | ---- | 45.45%-30M |
| Dividend (income)- adjustment | ---- | 33.33%-2M | ---- | 25.00%-3M | ---- | -300.00%-4M | ---- | 66.67%-1M | ---- | 25.00%-3M |
| Attributable subsidiary (profit) loss | ---- | 50.00%-1M | ---- | -200.00%-2M | ---- | 125.00%2M | ---- | -14.29%-8M | ---- | -333.33%-7M |
| Impairment and provisions: | ---- | 225.00%13M | ---- | -20.00%4M | ---- | 25.00%5M | ---- | -73.33%4M | ---- | --15M |
| -Impairmen of inventory (reversal) | ---- | --15M | ---- | ---- | ---- | 25.00%5M | ---- | -73.33%4M | ---- | --15M |
| -Impairment of trade receivables (reversal) | ---- | -150.00%-2M | ---- | --4M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -41.89%86M | ---- | 21.31%148M | ---- | -9.63%122M | ---- | -18.67%135M | ---- | 477.27%166M |
| -Fair value of investment properties (increase) | ---- | -41.22%87M | ---- | 22.31%148M | ---- | -10.37%121M | ---- | -11.76%135M | ---- | 447.73%153M |
| -Other fair value changes | ---- | ---1M | ---- | ---- | ---- | --1M | ---- | ---- | ---- | --13M |
| Asset sale loss (gain): | ---- | 0.00%-1M | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | 98.21%-1M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 0.00%-1M | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | ---1M |
| Depreciation and amortization: | ---- | -6.45%58M | ---- | 5.08%62M | ---- | 28.26%59M | ---- | 17.95%46M | ---- | 30.00%39M |
| -Amortization of intangible assets | ---- | 0.00%7M | ---- | 0.00%7M | ---- | 133.33%7M | ---- | 0.00%3M | ---- | 50.00%3M |
| Financial expense | ---- | 10.55%262M | ---- | 44.51%237M | ---- | 1.86%164M | ---- | -18.69%161M | ---- | -13.54%198M |
| Exchange Loss (gain) | ---- | ---3M | ---- | ---- | ---- | 80.95%-4M | ---- | ---21M | ---- | ---- |
| Special items | ---- | -10.00%9M | ---- | -64.29%10M | ---- | 100.00%28M | ---- | 16.67%14M | ---- | -7.69%12M |
| Operating profit before the change of operating capital | -14.20%139M | -74.34%107M | -22.49%162M | 36.72%417M | 23.67%209M | -45.34%305M | -27.78%169M | -15.33%558M | 141.24%234M | 77.15%659M |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -18.98%-326M |
| Accounts receivable (increase)decrease | 298.86%348M | -16.50%-233M | 13.79%-175M | -102.02%-200M | -243.97%-203M | -155.62%-99M | -65.10%141M | 168.73%178M | 2,226.32%404M | -463.04%-259M |
| Accounts payable increase (decrease) | -820.83%-442M | 9.88%456M | -182.35%-48M | 50.91%415M | 80.00%-17M | 161.38%275M | 84.38%-85M | -689.47%-448M | -180.41%-544M | 144.44%76M |
| Special items for working capital changes | ---- | 111.72%73M | ---- | -858.46%-623M | ---- | -247.73%-65M | ---- | -65.35%44M | ---- | -78.66%127M |
| Cash from business operations | 173.77%45M | 4,377.78%403M | -454.55%-61M | -97.84%9M | -104.89%-11M | 25.30%416M | 139.36%225M | 19.86%332M | 168.12%94M | -41.81%277M |
| Hong Kong profits tax paid | ---- | 37.37%-62M | ---- | 3.88%-99M | ---- | -68.85%-103M | ---- | 44.55%-61M | ---- | -2,100.00%-110M |
| China income tax paid | ---- | 50.00%-1M | ---- | 50.00%-2M | ---- | -33.33%-4M | ---- | 84.21%-3M | ---- | 85.82%-19M |
| Other taxs | 50.00%-13M | ---- | 38.10%-26M | ---- | -7.69%-42M | ---- | -30.00%-39M | ---- | 43.40%-30M | ---- |
| Special items of business | 62.86%114M | ---- | 152.63%70M | ---- | -180.61%-133M | ---- | 3,400.00%165M | ---- | -102.49%-5M | ---- |
| Net cash from operations | 958.82%146M | 469.57%340M | 90.86%-17M | -129.77%-92M | -152.99%-186M | 15.30%309M | 494.92%351M | 81.08%268M | 490.00%59M | -56.08%148M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 4.35%24M | ---- | -4.17%23M | ---- | 20.00%24M | ---- | -23.08%20M | ---- | -45.83%26M |
| Dividend received - investment | ---- | -33.33%2M | ---- | -25.00%3M | ---- | 300.00%4M | ---- | -66.67%1M | ---- | -25.00%3M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | -200.00%-3M | ---- | -133.33%-1M | ---- | -57.14%3M | ---- | -63.16%7M |
| Decrease in deposits (increase) | 36.84%26M | -146.15%-6M | -5.00%19M | 244.44%13M | 2,100.00%20M | -325.00%-9M | -105.88%-1M | 101.48%4M | 112.32%17M | -476.39%-271M |
| Sale of fixed assets | ---- | -50.00%1M | ---- | 100.00%2M | ---- | 0.00%1M | ---- | -50.00%1M | ---- | --2M |
| Purchase of fixed assets | ---- | 36.36%-7M | ---- | 42.11%-11M | ---- | -90.00%-19M | ---- | 54.55%-10M | ---- | -175.00%-22M |
| Sale of subsidiaries | ---- | ---- | ---- | 0.00%1M | ---- | -50.00%1M | ---- | -50.00%2M | ---- | -99.19%4M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---30M | ---30M | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | 225.00%26M | ---- | 60.00%8M | ---- | 66.67%5M | ---- | -62.50%3M | ---- | 300.00%8M |
| Cash on investment | ---- | -4.35%-48M | ---- | -283.33%-46M | ---24M | -300.00%-12M | ---- | 75.00%-3M | ---- | -9.09%-12M |
| Other items in the investment business | -75.00%1M | ---- | 136.36%4M | ---- | -466.67%-11M | ---- | -62.50%3M | ---- | 100.00%8M | ---- |
| Net cash from investment operations | 17.39%27M | 20.00%-8M | 253.33%23M | 72.22%-10M | 46.43%-15M | -271.43%-36M | -212.00%-28M | 108.24%21M | 119.23%25M | -126.21%-255M |
| Net cash before financing | 2,783.33%173M | 425.49%332M | 102.99%6M | -137.36%-102M | -162.23%-201M | -5.54%273M | 284.52%323M | 370.09%289M | 170.00%84M | -108.17%-107M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 66.43%957M | 39.77%991M | 22.08%575M | -53.20%709M | -64.37%471M | 235.18%1.52B | 1,336.96%1.32B | -66.91%452M | -87.88%92M | 33.01%1.37B |
| Refund | -555.26%-1.49B | 8.45%-596M | 54.94%-228M | -149.43%-651M | -1,104.76%-506M | 43.01%-261M | 52.81%-42M | 62.18%-458M | 89.23%-89M | 2.73%-1.21B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.4B |
| Interest paid - financing | 13.60%-108M | -13.30%-264M | -23.76%-125M | -39.52%-233M | -24.69%-101M | -16.78%-167M | -19.12%-81M | 8.33%-143M | 5.56%-68M | 27.78%-156M |
| Dividends paid - financing | ---- | 32.69%-35M | ---- | 32.47%-52M | ---- | -83.33%-77M | ---26M | 6.67%-42M | ---- | -87.50%-45M |
| Absorb investment income | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -2,569.57%-1.23B | ---1.23B | 96.91%-46M | ---- | -110.03%-1.49B |
| Other items of the financing business | 113.33%6M | 75.38%-16M | 40.79%-45M | -66.67%-65M | -68.89%-76M | -550.00%-39M | -45.16%-45M | 85.00%-6M | -6.90%-31M | ---40M |
| Net cash from financing operations | -461.02%-639M | 113.07%43M | 183.49%177M | -12.29%-329M | -114.14%-212M | -8.12%-293M | -3.13%-99M | -37.56%-271M | 40.00%-96M | 83.33%-197M |
| Effect of rate | 300.00%2M | 0.00%-2M | 75.00%-1M | 90.48%-2M | 63.64%-4M | -362.50%-21M | -320.00%-11M | -84.31%8M | 133.33%5M | 563.64%51M |
| Net Cash | -354.64%-466M | 187.01%375M | 144.31%183M | -2,055.00%-431M | -284.38%-413M | -211.11%-20M | 1,966.67%224M | 105.92%18M | 95.71%-12M | -337.50%-304M |
| Begining period cash | 57.12%1.03B | -39.87%653M | -39.87%653M | -3.64%1.09B | -3.64%1.09B | 2.36%1.13B | 2.36%1.13B | -18.69%1.1B | -18.69%1.1B | 9.46%1.35B |
| Cash at the end | -32.69%562M | 57.12%1.03B | 24.81%835M | -39.87%653M | -50.07%669M | -3.64%1.09B | 22.49%1.34B | 2.36%1.13B | 3.31%1.09B | -18.69%1.1B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.